Redeye: Hexatronic - Softer Sales Outlook for H2 2023
Redeye somewhat lowers its forecasts and Base Case for Hexatronic, following the softer sales outlook for H2 2023. We believe the sharp share price decline is mainly due to a loss of investor confidence rather than the softening outlook. We believe the mid-term case is intact, as the structural growth drivers remain.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/